Literature DB >> 23569223

Regulation of Torsin ATPases by LAP1 and LULL1.

Chenguang Zhao1, Rebecca S H Brown, Anna R Chase, Markus R Eisele, Christian Schlieker.   

Abstract

TorsinA is a membrane-associated AAA+ (ATPases associated with a variety of cellular activities) ATPase implicated in primary dystonia, an autosomal-dominant movement disorder. We reconstituted TorsinA and its cofactors in vitro and show that TorsinA does not display ATPase activity in isolation; ATP hydrolysis is induced upon association with LAP1 and LULL1, type II transmembrane proteins residing in the nuclear envelope and endoplasmic reticulum. This interaction requires TorsinA to be in the ATP-bound state, and can be attributed to the luminal domains of LAP1 and LULL1. This ATPase activator function controls the activities of other members of the Torsin family in distinct fashion, leading to an acceleration of the hydrolysis step by up to two orders of magnitude. The dystonia-causing mutant of TorsinA is defective in this activation mechanism, suggesting a loss-of-function mechanism for this congenital disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23569223      PMCID: PMC3637692          DOI: 10.1073/pnas.1300676110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Global unfolding of a substrate protein by the Hsp100 chaperone ClpA.

Authors:  E U Weber-Ban; B G Reid; A D Miranker; A L Horwich
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

2.  Purification of GroEL from an overproducing E. coli strain.

Authors:  E Quaite-Randall; A Joachimiak
Journal:  Methods Mol Biol       Date:  2000

Review 3.  Membrane budding and scission by the ESCRT machinery: it's all in the neck.

Authors:  James H Hurley; Phyllis I Hanson
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-30       Impact factor: 94.444

4.  FtsH recognizes proteins with unfolded structure and hydrolyzes the carboxyl side of hydrophobic residues.

Authors:  Y Asahara; K Atsuta; K Motohashi; H Taguchi; M Yohda; M Yoshida
Journal:  J Biochem       Date:  2000-05       Impact factor: 3.387

5.  Characterization of human torsinA and its dystonia-associated mutant form.

Authors:  Zhonghua Liu; Anna Zolkiewska; Michal Zolkiewski
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion.

Authors:  Teresa V Naismith; Seema Dalal; Phyllis I Hanson
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

7.  Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

8.  LULL1 retargets TorsinA to the nuclear envelope revealing an activity that is impaired by the DYT1 dystonia mutation.

Authors:  Abigail B Vander Heyden; Teresa V Naismith; Erik L Snapp; Didier Hodzic; Phyllis I Hanson
Journal:  Mol Biol Cell       Date:  2009-04-01       Impact factor: 4.138

9.  Alternative nuclear transport for cellular protein quality control.

Authors:  April Rose; Christian Schlieker
Journal:  Trends Cell Biol       Date:  2012-07-31       Impact factor: 20.808

10.  TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.

Authors:  Flávia C Nery; Juan Zeng; Brian P Niland; Jeffrey Hewett; Jonathan Farley; Daniel Irimia; Yuqing Li; Gerhard Wiche; Arnoud Sonnenberg; Xandra O Breakefield
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more
  68 in total

Review 1.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

2.  Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.

Authors:  Patricia K A Mongini; Jill M Kramer; Tomo-O Ishikawa; Harvey Herschman; Donna Esposito
Journal:  Clin Immunol       Date:  2014-03-29       Impact factor: 3.969

Review 3.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

4.  Arresting a Torsin ATPase reshapes the endoplasmic reticulum.

Authors:  April E Rose; Chenguang Zhao; Elizabeth M Turner; Anna M Steyer; Christian Schlieker
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

5.  The Torsin Activator LULL1 Is Required for Efficient Growth of Herpes Simplex Virus 1.

Authors:  Elizabeth M Turner; Rebecca S H Brown; Ethan Laudermilch; Pei-Ling Tsai; Christian Schlieker
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

6.  Putting a finger in the ring.

Authors:  John McCullough; Wesley I Sundquist
Journal:  Nat Struct Mol Biol       Date:  2014-12       Impact factor: 15.369

Review 7.  A designed repeat protein as an affinity capture reagent.

Authors:  Elizabeth B Speltz; Rebecca S H Brown; Holly S Hajare; Christian Schlieker; Lynne Regan
Journal:  Biochem Soc Trans       Date:  2015-10       Impact factor: 5.407

8.  LINCing defective nuclear-cytoskeletal coupling and DYT1 dystonia.

Authors:  Cosmo A Saunders; G W Gant Luxton
Journal:  Cell Mol Bioeng       Date:  2016-02-03       Impact factor: 2.321

9.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

10.  TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.

Authors:  Chun-Chi Liang; Lauren M Tanabe; Stephanie Jou; Frank Chi; William T Dauer
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.